Archive: November 12 2020


Immunotherapy Web Featured Images 20

STIC consensus statement on immunotherapy for the treatment of multiple myeloma

SITC convened an expert panel, which met to consider the current role of approved and emerging immunotherapy agents in MM and provide guidance to the oncology community by developing consensus recommendations. As immunotherapy evolves as a therapeutic option for the treatment of MM, these guidelines will be updated.

Visit website